Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Bardoxolone methyl, chronic kidney disease, and type 2 diabetes.

× No keyword cloud information.

7 in total

Review 1. Nrf2: a potential target for new therapeutics in liver disease.

Authors: A M Bataille; J E Manautou
Journal: Clin Pharmacol Ther Date: 2012-08-08 Impact factor: 6.875

2. Diabetic nephropathy: Could problems with bardoxolone methyl have been predicted?

Authors: Peter Rossing
Journal: Nat Rev Nephrol Date: 2013-02-05 Impact factor: 28.314

Review 3. Combating oxidative stress in diabetic complications with Nrf2 activators: how much is too much?

Authors: Sih Min Tan; Judy B de Haan
Journal: Redox Rep Date: 2014-02-21 Impact factor: 4.412

4. The extinguished BEACON of bardoxolone: not a Monday morning quarterback story.

Authors: John A Tayek; Kamyar Kalantar-Zadeh
Journal: Am J Nephrol Date: 2013-02-28 Impact factor: 3.754

Review 5. Prevention of diabetic complications by activation of Nrf2: diabetic cardiomyopathy and nephropathy.

Authors: Bing Li; Shujun Liu; Lining Miao; Lu Cai
Journal: Exp Diabetes Res Date: 2012-05-08

6. Keap1 hypomorphism protects against ischemic and obstructive kidney disease.

Authors: Roderick J Tan; Dionysios V Chartoumpekis; Brittney M Rush; Dong Zhou; Haiyan Fu; Thomas W Kensler; Youhua Liu
Journal: Sci Rep Date: 2016-11-02 Impact factor: 4.379

7. Renoprotection and the Bardoxolone Methyl Story - Is This the Right Way Forward? A Novel View of Renoprotection in CKD Trials: A New Classification Scheme for Renoprotective Agents.

Authors: Macaulay Onuigbo
Journal: Nephron Extra Date: 2013-04-27

7 in total